Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma
Authors:
- Jun‐Ichi TanumaJun‐Ichi Tanuma
- Kazumasa SugiharaKSKazumasa Sugihara
- Ichiro SembaISIchiro Semba
Open Access
Abstract
BACKGROUND.: Lymphatic vessel density (LVD) and microvessel density (MVD) are important parameters for assessing the malignant potential of tumors and patient survival. In this report, the authors defined LVD as the density of D2‐40‐positive lymphatic vessels and MVD as the density of CD105‐positive microvessels per unit area of tissue. It was reported previously that vascular endothelial growth factor C (VEGF‐C) is a major modulator of LVD and MVD. The objectives of this study were to clarify the clinical and prognostic significance of both LVD and MVD in oral squamous cell carcinoma (OSCC) and to elucidate the lymphangiogenic and angiogenic activities of VEGF‐C in cancer tissues.METHODS.: In total, 110 OSCC tissue samples were evaluated for LVD, MVD, and expression of VEGF‐C using immunohistochemistry. Correlations among these parameters and clinicopathologic factors were examined.RESULTS.: LVD was significantly higher in tumors that had very high expression of VEGF‐C compared with tumors that had no/weak expression of VEGF‐C. LVD correlated well with lymph node metastasis (P < .001). MVD was correlated significantly with positive lymph node metastasis (P < .001) but not with VEGF‐C expression. In contrast, high expression of VEGF‐C was correlated significantly with advanced tumor status (P = .041). Survival rates were lower in patients who had higher LVD (P < .001), higher MVD (P = .0028), and strong VEGF‐C expression (P = .048).CONCLUSIONS.: Lymphangiogenesis predominantly influenced metastasis‐free survival. The current results suggested that LVD is a more useful tool than MVD and VEGF‐C for deciding on therapeutic strategies in patients with OSCC. Cancer 2007. © 2007 American Cancer Society.Keywords
This publication has 31 references indexed in Scilit:
- First international consensus on the methodology of lymphangiogenesis quantification in solid human tumoursBritish Journal of Cancer, 2006
- Vascularity and expression of vascular endothelial growth factor in oral squamous cell carcinoma, resection margins, and nodal metastasesBritish Journal of Oral and Maxillofacial Surgery, 2006
- D2-40: A Reliable Marker in the Diagnosis of Pleural MesotheliomaPathobiology, 2006
- Expression of vascular endothelial growth factor‐C and its receptor in invasive micropapillary carcinoma of the breastPathology International, 2006
- Lymphangiogenesis and Angiogenesis in Bladder Cancer: Prognostic Implications and Regulation by Vascular Endothelial Growth Factors-A, -C, and -DClinical Cancer Research, 2006
- Clinicopathologic significance of CD105 expression in squamous cell carcinoma of the hypopharynxHead & Neck, 2005
- Lymphangiogenesis Correlates with Lymph Node Metastasis, Prognosis, and Angiogenic Phenotype in Human Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progressionJournal of Oral Pathology & Medicine, 2005
- Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervixLaboratory Investigation, 2005
- Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancerThe Prostate, 2002